Cargando…
Recent applications of quantitative systems pharmacology and machine learning models across diseases
Quantitative systems pharmacology (QSP) is a quantitative and mechanistic platform describing the phenotypic interaction between drugs, biological networks, and disease conditions to predict optimal therapeutic response. In this meta-analysis study, we review the utility of the QSP platform in drug...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528185/ https://www.ncbi.nlm.nih.gov/pubmed/34671863 http://dx.doi.org/10.1007/s10928-021-09790-9 |
_version_ | 1784586206701420544 |
---|---|
author | Aghamiri, Sara Sadat Amin, Rada Helikar, Tomáš |
author_facet | Aghamiri, Sara Sadat Amin, Rada Helikar, Tomáš |
author_sort | Aghamiri, Sara Sadat |
collection | PubMed |
description | Quantitative systems pharmacology (QSP) is a quantitative and mechanistic platform describing the phenotypic interaction between drugs, biological networks, and disease conditions to predict optimal therapeutic response. In this meta-analysis study, we review the utility of the QSP platform in drug development and therapeutic strategies based on recent publications (2019–2021). We gathered recent original QSP models and described the diversity of their applications based on therapeutic areas, methodologies, software platforms, and functionalities. The collection and investigation of these publications can assist in providing a repository of recent QSP studies to facilitate the discovery and further reusability of QSP models. Our review shows that the largest number of QSP efforts in recent years is in Immuno-Oncology. We also addressed the benefits of integrative approaches in this field by presenting the applications of Machine Learning methods for drug discovery and QSP models. Based on this meta-analysis, we discuss the advantages and limitations of QSP models and propose fields where the QSP approach constitutes a valuable interface for more investigations to tackle complex diseases and improve drug development. |
format | Online Article Text |
id | pubmed-8528185 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-85281852021-10-21 Recent applications of quantitative systems pharmacology and machine learning models across diseases Aghamiri, Sara Sadat Amin, Rada Helikar, Tomáš J Pharmacokinet Pharmacodyn Review Paper Quantitative systems pharmacology (QSP) is a quantitative and mechanistic platform describing the phenotypic interaction between drugs, biological networks, and disease conditions to predict optimal therapeutic response. In this meta-analysis study, we review the utility of the QSP platform in drug development and therapeutic strategies based on recent publications (2019–2021). We gathered recent original QSP models and described the diversity of their applications based on therapeutic areas, methodologies, software platforms, and functionalities. The collection and investigation of these publications can assist in providing a repository of recent QSP studies to facilitate the discovery and further reusability of QSP models. Our review shows that the largest number of QSP efforts in recent years is in Immuno-Oncology. We also addressed the benefits of integrative approaches in this field by presenting the applications of Machine Learning methods for drug discovery and QSP models. Based on this meta-analysis, we discuss the advantages and limitations of QSP models and propose fields where the QSP approach constitutes a valuable interface for more investigations to tackle complex diseases and improve drug development. Springer US 2021-10-20 2022 /pmc/articles/PMC8528185/ /pubmed/34671863 http://dx.doi.org/10.1007/s10928-021-09790-9 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Paper Aghamiri, Sara Sadat Amin, Rada Helikar, Tomáš Recent applications of quantitative systems pharmacology and machine learning models across diseases |
title | Recent applications of quantitative systems pharmacology and machine learning models across diseases |
title_full | Recent applications of quantitative systems pharmacology and machine learning models across diseases |
title_fullStr | Recent applications of quantitative systems pharmacology and machine learning models across diseases |
title_full_unstemmed | Recent applications of quantitative systems pharmacology and machine learning models across diseases |
title_short | Recent applications of quantitative systems pharmacology and machine learning models across diseases |
title_sort | recent applications of quantitative systems pharmacology and machine learning models across diseases |
topic | Review Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528185/ https://www.ncbi.nlm.nih.gov/pubmed/34671863 http://dx.doi.org/10.1007/s10928-021-09790-9 |
work_keys_str_mv | AT aghamirisarasadat recentapplicationsofquantitativesystemspharmacologyandmachinelearningmodelsacrossdiseases AT aminrada recentapplicationsofquantitativesystemspharmacologyandmachinelearningmodelsacrossdiseases AT helikartomas recentapplicationsofquantitativesystemspharmacologyandmachinelearningmodelsacrossdiseases |